Asamer, E., Szkandera, J., Gibiser, P., Lembeck, A. L., Stojakovic, T., Kornprat, P., . . . Stotz, M. (2018). Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer: A retrospective analysis. Wien Klin Wochenschr.
Citação norma ChicagoAsamer, Eva, et al. "Elevated Amylase in Plasma Represents an Adverse Prognostic Marker in Patients With Metastatic Pancreatic Cancer: A retrospective Analysis." Wien Klin Wochenschr 2018.
MLA CitationAsamer, Eva, et al. "Elevated Amylase in Plasma Represents an Adverse Prognostic Marker in Patients With Metastatic Pancreatic Cancer: A retrospective Analysis." Wien Klin Wochenschr 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.